Literature DB >> 16568892

Lentiviral vectors.

Nils Loewen1, Eric M Poeschla.   

Abstract

We review the use of lentiviral vectors in current human gene therapy applications that involve genetic modification of nondividing tissues with integrated transgenes. Safety issues, including insertional mutagenesis and replication-competent retroviruses, are discussed. Innate cellular defenses against retroviruses and their implications for human gene therapy with different lentiviral vectors are also addressed.

Entities:  

Mesh:

Year:  2005        PMID: 16568892     DOI: 10.1007/10_007

Source DB:  PubMed          Journal:  Adv Biochem Eng Biotechnol        ISSN: 0724-6145            Impact factor:   2.635


  15 in total

Review 1.  Integrase, LEDGF/p75 and HIV replication.

Authors:  E M Poeschla
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

2.  Prolonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway of nonhuman primates.

Authors:  Román A Barraza; Carol A Rasmussen; Nils Loewen; J Douglas Cameron; B'Ann T Gabelt; Wu-Lin Teo; Paul L Kaufman; Eric M Poeschla
Journal:  Hum Gene Ther       Date:  2009-03       Impact factor: 5.695

Review 3.  Recent advances in lentiviral vector development and applications.

Authors:  Janka Mátrai; Marinee K L Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

4.  The HIV-1 central polypurine tract functions as a second line of defense against APOBEC3G/F.

Authors:  Chunling Hu; Dyana T Saenz; Hind J Fadel; William Walker; Mary Peretz; Eric M Poeschla
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

5.  RhoA GTPase-induced ocular hypertension in a rodent model is associated with increased fibrogenic activity in the trabecular meshwork.

Authors:  Padmanabhan P Pattabiraman; Tommy Rinkoski; Eric Poeschla; Alan Proia; Pratap Challa; Ponugoti V Rao
Journal:  Am J Pathol       Date:  2014-12-12       Impact factor: 4.307

6.  Prostaglandin pathway gene therapy for sustained reduction of intraocular pressure.

Authors:  Román A Barraza; Jay W McLaren; Eric M Poeschla
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

Review 7.  Human gene therapy vectors derived from feline lentiviruses.

Authors:  Román A Barraza; Eric M Poeschla
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

8.  Immunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in mice.

Authors:  Giou-Teng Yiang; Horng-Jyh Harn; Yung-Luen Yu; Sheng-Chuan Hu; Yu-Ting Hung; Chia-Jung Hsieh; Shinn-Zong Lin; Chyou-Wei Wei
Journal:  J Biomed Sci       Date:  2009-05-07       Impact factor: 8.410

Review 9.  Intensive RNAi with lentiviral vectors in mammalian cells.

Authors:  Tanner Miest; Dyana Saenz; Anne Meehan; Manuel Llano; Eric M Poeschla
Journal:  Methods       Date:  2008-11-28       Impact factor: 3.608

Review 10.  Gene transfer to the outflow tract.

Authors:  Yalong Dang; Ralitsa Loewen; Hardik A Parikh; Pritha Roy; Nils A Loewen
Journal:  Exp Eye Res       Date:  2016-04-27       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.